Kempen Pharma SRL
Kempen Pharma reported total assets of €3.57m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026).
The score of Kempen Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +104 % Total assets +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kempen Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Kempen Pharma's financial analysis
- Solvency75.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kempen Pharma
Kempen Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0538.871.226
- VAT number
- BE0538871226
- Peppol
- Registered · 0208:0538871226 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2013
- Registered office
- 2990 Wuustwezel
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Kempen Pharma (SRL) has been based in Wuustwezel since 2013, active in: activities of holding companies. For 2025, it reports a net profit of 647,955 € and equity of €2.69m; its revenue is not published. Its solvency stands at 75.3%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kempen Pharma
Companies in the same business, of comparable size and area, outside its group.
- BE-FIN Activities of holding companies Knokke-Heist · balance sheet €3.57m
- JT Holdco Activities of holding companies Kuurne · balance sheet €3.57m
- H&V-Immo Activities of holding companies Wevelgem · balance sheet €3.56m
- Obus - de Galan Activities of holding companies Aalst · balance sheet €3.56m
- SFH Activities of holding companies Evergem · balance sheet €3.57m
- Invis Activities of holding companies Hooglede · balance sheet €3.57m
- Baucotech Activities of holding companies Maldegem · balance sheet €3.58m
- RED1 Activities of holding companies Bruges · balance sheet €3.56m
Frequently asked questions about Kempen Pharma
What is the revenue of Kempen Pharma?
Kempen Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kempen Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0538871226 for Kempen Pharma, if the company is VAT-registered. Its company number (CBE) is 0538.871.226.
Where is the registered office of Kempen Pharma?
According to the CBE register, the registered office of Kempen Pharma is in 2990 Wuustwezel.
What is the equity of Kempen Pharma?
At the close of the 2025 financial year, the equity of Kempen Pharma amounts to 2,686,473 €, a solvency of 75.3% of total assets.
Who manages Kempen Pharma?
The register lists 1 active mandates at Kempen Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kempen Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →